🇺🇸 FDA
Patent

US 7871986

Methods of stimulating an immune response against prostate specific antigen

granted A61KA61K2035/124A61K2039/5154

Quick answer

US patent 7871986 (Methods of stimulating an immune response against prostate specific antigen) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61K, A61K2035/124, A61K2039/5154, A61K2039/5156, A61K2039/5158